In the first three months of 2021 we’ve featured 11 new biotech companies. Below is the full list. You can also head over to the VentureRadar Database to find 1000s of similar biotech startups.
Dunad Therapeutics
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies, which it says overcome several of the major challenges with current degradation platforms, including oral bioavailability and CNS exposure…. [Read full post] [View VentureRadar Profile] [View Similar Companies on VentureRadar]
SENICA
SENISCA is a spinout company from the University of Exeter, founded in 2020 to develop new approaches to reverse cellular senescence (ageing) and treat diseases and aesthetic aspects of ageing. SENISCA says it has discovered a new and druggable means to reverse senescence through modulation of RNA splicing… [Read full post] [View VentureRadar Profile] [View Similar Companies on VentureRadar]
Delonix Bioworks
Delonix Bioworks is a Shanghai-based startup using synthetic biology to design bacteria to act as safer and more effective vaccines against bacterial infections and cancer. The Delonix team has developed a novel approach that builds on the established concept of live attenuated bacteria and combines it with the latest developments in synthetic biology… [Read full post] [View VentureRadar Profile] [View Similar Companies on VentureRadar]
Orna Therapeutics
Orna Therapeutics is an MIT spin-off developing fully engineered circular RNA (oRNA) therapeutics, a new class of RNA medicines with the potential to treat a wide range of diseases including cancer, autoimmune, and genetic disorders… [Read full post] [View VentureRadar Profile] [View Similar Companies on VentureRadar]
Baccuico
Baccuico has developed a proprietary bacterial cultivation platform that combines directed evolution, next generation sequencing, and machine learning to access novel compounds from biological ‘dark matter’. The company’s Bacterial Community Cultivation platform (BACCU) directs the evolution of unculturable bacteria, so that the bacteria evolve to become culturable in the lab… [Read full post] [View VentureRadar Profile] [View Similar Companies on VentureRadar]
ExploRNA Therapeutics
ExploRNA Therapeutics is a spin-off from the University of Warsaw, developing next generation mRNA technology for applications such as anti-cancer vaccines. ExploRNA Therapeutics was founded by Professor Jacek Jemielity, Head of the Bio Organic Chemistry Laboratory at the Center of New Technologies CeNT at the University of Warsaw… [Read full post] [View VentureRadar Profile] [View Similar Companies on VentureRadar]
Acrigen Biosciences
Acrigen Biosciences is developing technologies to improve the efficiency and enhance the safety of CRISPR-Cas based gene editing, with the aim of eliminating the threat of unintended editing causing severe complications and side effects… [Read full post] [View VentureRadar Profile] [View Similar Companies on VentureRadar]
New Equilibrium Biosciences
New Equilibrium Biosciences has developed a computational–experimental platform to discover lead drug candidates that regulate intrinsically disordered proteins implicated in cancers and neurodegenerative disorders. The company says that about 30% of proteins are predicted to not have a single 3D structure… [Read full post] [View VentureRadar Profile] [View Similar Companies on VentureRadar]
ROME Therapeutics
Rome Therapeutics was founded to develop novel therapies for cancer and autoimmune diseases by leveraging new insights from the vast uncharted territory of the repeatome. The repeatome makes up 60% of our genome and consists of repetitive sequences of nucleic acids, known as repeats… [Read full post] [View VentureRadar Profile] [View Similar Companies on VentureRadar]
Allozymes
Allozymes is applying innovative ultrahigh-throughput microfluidics technology to accelerate enzyme evolution and development. The company’s first target application is to transform ingredients manufacturing for industries ranging from pharmaceuticals and cosmetics to food and beverages… [Read full post] [View VentureRadar Profile] [View Similar Companies on VentureRadar]
Blacksmith Medicines
Blacksmith Medicines is using its purpose-built platform for metalloenzyme-targeted medicines to rationally design small molecule inhibitors for novel targets in immuno-oncology and inflammatory diseases. The company, which is a spin-out of Forge Therapeutics, was officially launched in early 2021 with seed funding and a research collaboration with Eli Lilly and Company… [Read full post] [View VentureRadar Profile] [View Similar Companies on VentureRadar]